Phase III trial
Pharnext CMT drug shows positive Phase III results
April 29, 2021CMT, Charcot-Marie-Tooth Disease, Phase III trial, pharma, pharma news, pharnext
Pharnext SA’s PXT3003 treatment for patients with Charcot-Marie-Tooth Disease (CMT) has shown positive interim results in its ongoing Phase III …
GSK & Vir’s COVID-19 treatment shows 85% efficacy in Phase III trial
March 29, 2021Sales and Marketing COVID-19, GSK, Phase III trial, covid-19 treatment, vir
GSK and Vir Biotechnology have submitted an Emergency Use Authorization request to the FDA for their VIR-7831 therapy for the …
Pfizer and Myovant’s menstrual blood loss treatment reports 78% effectiveness
March 24, 2021Research and Development Myovant, Pfizer, Phase III trial, fibroids, uterine fibroids
Pfizer and Myovant Science’s relugolix treatment to reduce menstrual blood loss in women with uterine fibroids has shown promising results …
Roche’s Huntington’s disease treatment disappoints in Phase III trial
March 23, 2021Manufacturing and Production Huntington's, Phase III trial, Roche, huntington's disease, tominersen
Roche has discontinued dosing in a Phase III trial of its tominersen treatment for Huntington’s disease, following discouraging initial data.
Lilly’s ulcerative colitis treatment meets all key endpoints in Phase III trial
March 17, 2021Research and Development Eli Lilly, Phase III trial, lilly, mirikizumab, ulcerative colitis
Eli Lilly’s mirikizumab treatment for ulcerative colitis (UC) patients has met the primary endpoints and all key secondary endpoints in …
AstraZeneca to discontinue trial for heart disease drug Epanova
January 13, 2020Sales and Marketing AstraZeneca, Phase II Trial, Phase III trial, heart disease, triglycerides
AstraZeneca expects a $100 million writedown for its heart disease drug Epanova, as it discontinues its late stage trial. This …
Positive Phase III results for Amgen’s Repatha for coronary artery disease
September 21, 2016Research and Development Amgen, Phase III trial, Repatha
Amgen has announced that its monoclonal antibody Repatha (evolocumab) achieved positive Phase III results for the treatment of coronary artery …
Latest content
FibroFind appoints Lee Borthwick as CEO
